help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2401
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Redman, L. M.
Right arrow Articles by Norman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Redman, L. M.
Right arrow Articles by Norman, R. J.
Related Collections
Right arrow Female Endocrinology
Right arrow Metabolism
Right arrow Obesity
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 7 3830-3837
Copyright © 2005 by The Endocrine Society

Effect of a Synthetic Progestin on the Exercise Status of Sedentary Young Women

Leanne M. Redman, Garry C. Scroop, Goran Westlander and Robert J. Norman

Exercise Physiology Research Unit (L.M.R.), Discipline of Physiology, and Reproductive Medicine Unit (L.M.R., G.W., R.J.N.), Department of Obstetrics and Gynaecology, University of Adelaide; and Department of Thoracic Medicine (G.C.S.), Royal Adelaide Hospital, Adelaide SA 5000, Australia

Address all correspondence and requests for reprints to: Leanne M. Redman, Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, Louisiana 70808-4124. E-mail: Leanne.Redman{at}PBRC.edu.

Context: The impact of progestins on exercise performance in women has not been previously studied.

Objective: The objective of this study was to examine the effect of a synthetic progestin on aspects of exercise status in young women.

Design, Patients, Setting: Twenty-three young, healthy, habitually sedentary women participated in a single-blind, randomized, counterbalanced, cross-over study in a university-based laboratory setting.

Intervention: Two monophasic oral contraceptive pills (OCPs) were administered in which the dose of the synthetic progestin, norethisterone, was 2-fold different but the dose of the synthetic estrogen, ethinyl estradiol, was constant. During each month of OCP aspects of exercise status were assessed during incremental exercise to exhaustion and steady-state submaximal exercise and with a performance test.

Main Outcome Measures: The main outcome measures were peak oxygen uptake (O2peak), respiratory exchange ratio (RER), time to exhaustion, lactate concentrations, and total work done.

Results: Peak heart rates were approximately 95% of age-predicted values with both OCP preparations, whereas O2peak was approximately 30% above age-predicted values. Peak postincremental exercise plasma lactate concentrations exceeded those reported for males and females, whereas the RER was below expected values throughout both incremental and steady-state exercise. The effects on O2peak and RER were increased with the higher dose progestin OCP, as were exercise time to exhaustion and total work done.

Conclusion: Synthetic progestins in OCP formulations can have a significant effect on the exercise status of young, sedentary women, possibly through an effect on stroke volume and a shift in the principal energy substrate used during exercise from carbohydrate to lipid.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society